|
|
|
|
Дата |
|---|
| 24.12.2025 |
| 23.12.2025 |
| 22.12.2025 |
| 19.12.2025 |
| 18.12.2025 |
| 17.12.2025 |
| 11.12.2025 |
| 10.12.2025 |
| 09.12.2025 |
| 08.12.2025 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
|---|---|---|---|---|---|---|---|
|
6.00
|
6.15
|
6.29
|
6.05
|
6.36
|
6.05
|
|
|
45 824.73
|
387.00
|
|
5.75
|
6.90
|
6.51
|
5.83
|
6.99
|
6.14
|
|
|
324 074.08
|
1 002.00
|
|
6.46
|
7.45
|
6.58
|
6.39
|
8.03
|
6.42
|
|
|
1 018 323.20
|
1 132.00
|
|
6.50
|
7.04
|
5.46
|
5.46
|
7.05
|
6.78
|
|
|
526 196.74
|
761.00
|
|
5.46
|
5.85
|
5.51
|
5.25
|
5.804
|
5.53
|
|
|
134 299.94
|
379.00
|
|
5.40
|
5.66
|
5.55
|
4.9507
|
5.69
|
5.39
|
|
|
244 624.38
|
1 448.00
|
|
5.89
|
5.95
|
5.95
|
5.40
|
6.00
|
5.95
|
|
|
297 570.50
|
690.00
|
|
5.10
|
5.92
|
5.34
|
5.34
|
6.25
|
5.92
|
|
|
291 097.97
|
1 038.00
|
|
5.20
|
5.80
|
4.93
|
4.7651
|
5.64
|
5.56
|
|
|
513 420.24
|
1 375.00
|
|
4.58
|
4.90
|
4.64
|
4.28
|
6.0999
|
4.90
|
|
|
1 100 088.30
|
3 005.00
|
Axe Compute Inc., formerly Predictive Oncology Inc., is engaged in using artificial intelligence (AI) and machine learning to expedite early drug discovery and enable drug development for the benefit of cancer patients worldwide. The Company’s scientifically validated AI platform, PEDAL, is able to predict with 92% accuracy when a tumor sample responds to a certain drug compound, allowing for a more informed selection of drug/tumor type combinations for subsequent in-vitro testing. Through AI, it uses its proprietary biobank of 150,000+ cancer tumor samples, categorized by patient type, against drug compounds to help the drug discovery process and increase the probability of drug development.
The Company offers a suite of solutions for oncology drug development from early discovery to clinical trials.
Показать все Скрыть